This weekend, we’re honored to convene leading international experts in
#MOGAD research & care for the International Expert Panel on Research Directions in MOGAD in Cambridge, Massachusetts!
Together, global clinicians, researchers, advocates, & industry leaders will collaborate to help shape the future of
#MOGAD research, treatment development, and patient care.
We’re especially excited for discussions focused on:
🔹 Worldwide disease patterns and diagnostic access
🔹 Mechanistic and biomarker research priorities
🔹 Future approved therapeutics for MOGAD
🔹 Quality of life, cognitive and behavioral health, and long-term outcome research
🔹 The patient experience and its critical role in shaping future research directions
A major goal of this meeting is to identify the field’s most urgent research gaps and future priorities — work that will help guide advocacy efforts, regulatory decision-making, and the development of a publishable consensus paper for a leading neurology journal.
We’re deeply grateful to the incredible experts and patient voices contributing to these conversations, and to our sponsors, including UCB Biopharma and Genentech, a member of the Roche Group, for supporting this important gathering.
We look forward to sharing more from the weekend ahead!
@FabienneBrilot @darshi_r @IzzyCotter @mlevy18 @MGHNeurology @ucb_news @Roche @Mayo_AING